Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03719482 · ClinicalTrials.gov registry record · Phase 1
Assessment of the Biodistribution and Safety of [18F]MNI-1054
A Phase 1 study, sponsored by Invicro.
- Completed
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
NCT03719482 is a Phase 1 study that has completed, run by Invicro. The registered enrollment target is 4 participants.
The verdict
NCT03719482, a Phase 1 study, has completed, sponsored by Invicro.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
The overall goal of this protocol is to evaluate the biodistribution of \[18F\]MNI-1054 as a LSD1 targeted radiopharmaceutical.
Interventions
- DRUG [18F]MNI-1054
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2018-10-05 |
| Est. Completion | 2019-05-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03719482
The ClinicalTrials.gov registry entry for NCT03719482 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Invicro, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [18F]MNI-1054 is the first listed.
NCT03719482 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03719482 about?
NCT03719482 is a clinical study titled "Assessment of the Biodistribution and Safety of [18F]MNI-1054". The overall goal of this protocol is to evaluate the biodistribution of \[18F\]MNI-1054 as a LSD1 targeted radiopharmaceutical.
What is the current status of trial NCT03719482?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2018-10-05. Estimated completion is 2019-05-02.
What interventions are being tested in trial NCT03719482?
The interventions under investigation include: [18F]MNI-1054 (DRUG).
Who is sponsoring clinical trial NCT03719482?
This trial is sponsored by Invicro, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.